Press Releases
Bioxodes’ antithrombotic meets development milestones – Company to launch Series A financing round to bring product to the clinic
Marche-en-Famenne, Belgium, 2015
Bioxodes SA, the Belgian-based start-up developing pharmaceutical products derived from natural sources, announces that it has successfully brought its lead product, Ir-CPI, trough pre-clinical development confirming its potential as the first in a new class of antithrombotic medicines. The company is now poised to initiate the studies required for clinical entry.